Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic illness often triggered by an initiating acute event, mainly viral infections. The transition from acute to chronic disease remains unknown, but interest in this phenomenon has escalated since the COVID-19 pandemic and the post-COVID-19 illness, termed ‘long COVID’ (LC). Both ME/CFS and LC share many clinical similarities. Here, we present recent findings in ME/CFS research focussing on proposed disease pathologies shared with LC. Understanding these disease pathologies and how they influence each other is key to developing effective therapeutics and diagnostic tests. Given that ME/CFS typically has a longer disease duration compared with LC, with symptoms and pathologies evolving over time, ME/CFS may provide insights into the future progression of LC.
Funding
S.J.A. and E.K.J. were supported by the Judith Jane Mason & Harold Stannet Williams Memorial Foundation (The Mason Foundation). S.J.A. and D.M. were supported by ME Research UK (SCIO Charity Number SC036942), with the financial support of The Fred and Joan Davies Bequest, and C.W.A. was supported by the Open Medicine Foundation.